About Omnipod® Products

The Omnipod® 5 Automated Insulin Delivery System and the Omnipod DASH® Insulin Management System

Omnipod® combines a small, tubeless, waterproof*, wearable device (the Pod) with a handheld device, the Personal Diabetes Manager (PDM), also called a Controller. Fill the Pod with insulin and it can be worn directly on the body almost anywhere you would administer an insulin injection. The Pod communicates wirelessly† with the PDM/Controller to program insulin delivery.

Whether your patient is newly diagnosed with diabetes, currently receives daily insulin injections, or is considering a switch from another insulin pump, one of our Omnipod products may be the right insulin management option.

†At start-up, the Pod and PDM/Controller must be adjacent and touching. During normal operation, the PDM/Controller must be within 1.5 metres of the Pod.
*The Pod has a waterproof IP28 rating for up to 7.6 metres for 60 minutes. The PDM/Controller is not waterproof.

Introducing the Omnipod® 5 Automated Insulin Delivery System

Omnipod 5 Omnipod 5
Screen image is an example, for illustrative purposes only. Pod shown without the necessary adhesive. *Sensors are sold separately and require a separate prescription.
  • The first and only tubeless automated insulin delivery (AID) system compatible with the leading sensor brands.**
  • Built-in SmartAdjust™ technology adjusts basal insulin so you don’t have to and helps to correct highs and protect from lows1-3
  • Customisable glucose targets can accommodate your patients’ routines
  • SmartBolus calculator is informed with sensor value and trend for bolus recommendations
Omnipod® 5 AID System
**Dexcom G6, Dexcom G7 and FreeStyle Libre 2 Plus sensors.

Introducing Omnipod DASH® Insulin Management System

Omnipod 5 Omnipod 5
  • Pod therapy may help simplify life for your patients with type 1 diabetes, by providing an alternative to Multiple Daily Injections (MDI)
  • It’s tubeless, waterproofΩ and wearable
  • Set a Zero Basal Rate for time when low insulin delivery is needed
  • Set Fractional Insulin to Carb Ratios (0.1g/U) for insulin sensitivity
  • Set various presets to establish favourites, tag activities and personalise insulin delivery based on daily routine
Omnipod DASH® System
ΩThe Pod has a waterproof IP28 rating for up to 7.6 metres for 60 minutes. The PDM is not waterproof.

1. In Automated Mode, SmartAdjust technology uses your total daily insulin (TDI) to set a new Adaptive Basal Rate for you.

2. Brown S. et al. Diabetes Care. 2021;44:1630-1640. Prospective pivotal trial in 240 participants with T1D aged 6 - 70 yrs. Study included a 14-day standard therapy (ST) phase followed by a 3-month Omnipod 5 hybrid closed-loop (HCL) phase. Mean time in hyperglycaemic range (>10.0 mmol/L or >180mg/dL) as measured by CGM in adults/adolescents and children ST vs. 3-mo Omnipod 5: 28.9% vs. 22.8%; 44.8% vs 29.7%, P<0.0001, respectively. Mean time in hypoglycaemic range (<3.9 mmol/L or <70 mg/dL) as measured by CGM in adults/adolescents and children ST vs. 3-mo Omnipod 5: 2.89% vs. 1.32%, P<0.0001; 2.21% vs. 1.78, P=0.8153, respectively.

3. Sherr J. et al. Diabetes Care. 2022; 45:1907-1910. Single-arm multicenter clinical trial in 80 pre-school children (aged 2- 5.9 yrs) with T1D. Study included a 14-day standard therapy (ST) phase followed by a 3-month AID phase with Omnipod 5 system. Mean time in hyperglycaemic range (>10.0 mmol/L or >180mg/dL) as measured by CGM in children ST vs. 3-mo Omnipod 5: 39.4% vs. 29.5%, P<0.0001, respectively. Mean time in hypoglycaemic range (<3.9 mmol/L or <70 mg/dL) as measured by CGM in children ST vs. 3-mo Omnipod 5: 3.43% vs. 2.46%, P=0.0204.